BSE filing, NSE: DRAGARWQ. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,400.00
- Market cap
- ₹2,538 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 33.3×Sector 53.4×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Acquisition Worth ₹711.2 Cr
Dr. Agarwal's Eye Hospital Limited has completed its amalgamation with Dr. Agarwal's Health Care Limited, with the transaction valued at ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwal's Eye Hospital Acquisition
Dr. Agarwal's Eye Hospital announced the effectiveness of its Scheme of Amalgamation starting November 01, 2026, and fixed a record date for share allotment.
Dr. Agarwal's Eye Hospital Other Announcement
The company submitted its quarterly shareholding pattern as mandated by SEBI. The filing provides a breakdown of shareholdings among promoters and the public.
Dr. Agarwal's Eye Hospital Acquisition
The NCLT Chennai Bench has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The company awaits the order copy.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Other board meeting date announcements
All →Lovable Lingerie Board Meeting Date
Lovable Lingerie will hold a board meeting on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window is closed from 1 October 2026 until 16 November 2026.
DPSC Board Meeting Date
DPSC Limited will hold a board meeting on 13 November 2026 to approve unaudited half-yearly results. Trading window closes from 1 October until 15 November 2026.
PTC Industries Board Meeting Date
PTC Industries intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-yearly financial results for the period ended September 2026. The trading window is closed from 1 October to 16 November 2026.
Godavari Drugs Board Meeting Date
Godavari Drugs will hold a board meeting on 11 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.
Beryl Drugs Board Meeting Date
Beryl Drugs Ltd has notified a board meeting on 14 November 2026 to consider unaudited results for the quarter ended 30 September 2026 and the limited review report. The trading window stays closed until 48 hours after the meeting.
Prime Focus Board Meeting Date
Prime Focus has scheduled a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results.